Loading clinical trials...
Loading clinical trials...
The purpose of this study is to assess clinical utility of combined circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) in the diagnosis of primary lung cancer.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Samsung Medical Center
NCT07510724 · Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), and more
NCT07410676 · Cancer, Sarcoma, and more
NCT07239063 · CRC (Colorectal Cancer), Lung Cancer (Diagnosis)
NCT07393490 · Lung Cancer (Diagnosis)
NCT07255950 · Lung Cancer (Diagnosis), Biopsy, Fine-Needle/Methods
Samsung Medical Center
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions